Skip to main content

Peer Review reports

From: A composite biomarker of neutrophil-lymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers

Original Submission
24 Feb 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
6 Mar 2021 Reviewed Reviewer Report
8 Mar 2021 Reviewed Reviewer Report
2 Apr 2021 Author responded Author comments - Shuyu D. Li
Resubmission - Version 3
2 Apr 2021 Submitted Manuscript version 3
7 Apr 2021 Reviewed Reviewer Report
12 Apr 2021 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
13 Apr 2021 Editorially accepted
21 Apr 2021 Article published 10.1186/s12885-021-08194-9

You can find further information about peer review here.

Back to article page